自膨胀TAVI与外科主动脉瓣置换术后结构性瓣膜退化的5年比较
该事后分析汇总了CoreValve US High Risk Pivotal和SURTAVI随机试验及两项非随机研究,评估中高危患者自膨胀TAVI或外科术后5年结构性瓣膜退化(SVD)的发生率及结局。结果显示TAVI组SVD累积发生率低于外科组(2.20% vs 4.38%;HR 0.46;95%CI 0.27-0.78;
要点
- 自膨胀TAVI术后5年SVD发生率低于外科手术(2.20% vs 4.38%)。
- 小瓣环(≤23 mm)患者中TAVI的SVD风险优势更显著(HR 0.21)。
- SVD与5年全因死亡、心血管死亡和心衰住院风险增加相关。
核心结论
- 在中高危主动脉瓣狭窄患者中,自膨胀TAVI术后5年SVD发生率低于外科手术。
- SVD与5年全因死亡、心血管死亡及瓣膜病或心衰恶化住院风险增加独立相关。
研究设计与样本
- 事后分析汇总CoreValve US High Risk Pivotal(n=615)和SURTAVI(n=1484)随机试验,并补充CoreValve Extreme Risk Pivotal(n=485)和CoreValve Continued Access Study(n=2178)。
- 共纳入4762例患者,其中随机试验2099例(TAVI 1128例,外科971例),非随机TAVI 2663例;男性2605例(54.7%),平均年龄82.1(7.4)岁。
- SVD定义:平均压差较出院或30天时增加≥10 mmHg且最终平均压差≥20 mmHg,或新发中度及以上瓣内主动脉瓣反流或反流程度增加≥1级。
关键数值与推荐
- SVD判定标准:平均压差较出院或30天增加≥10 mmHg且最终平均压差≥20 mmHg,或新发中度及以上瓣内主动脉瓣反流或反流程度增加≥1级。
临床怎么用
- 多普勒超声心动图是检测SVD的有价值工具,术后应规律随访以早期识别SVD。
- 对于小瓣环(≤23 mm)患者,自膨胀TAVI在5年SVD风险上可能优于外科手术。
- 发生SVD的患者临床结局较差,需加强监测和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The frequency and clinical importance of structural valve deterioration (SVD) in patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) or surgery is poorly understood. OBJECTIVE: To evaluate the 5-year incidence, clinical outcomes, and predictors of hemodynamic SVD in patients undergoing self-expanding TAVI or surgery. DESIGN, SETTING, AND PARTICIPANTS: This post hoc analysis pooled data from the CoreValve US High Risk Pivotal (n = 615) and SURTAVI (n = 1484) randomized clinical trials (RCTs); it was supplemented by the CoreValve Extreme Risk Pivotal trial (n = 485) and CoreValve Continued Access Study (n = 2178). Patients with severe aortic valve stenosis deemed to be at intermediate or increased risk of 30-day surgical mortality were included. Data were collected from December 2010 to June 2016, and data were analyzed from December 2021 to October 2022. INTERVENTIONS: Patients were randomized to self-expanding TAVI or surgery in the RCTs or underwent self-expanding TAVI for clinical indications in the nonrandomized studies. MAIN OUTCOMES AND MEASURES: The primary end point was the incidence of SVD through 5 years (from the RCTs). Factors associated with SVD and its association with clinical outcomes were evaluated for the pooled RCT and non-RCT population. SVD was defined as (1) an increase in mean gradient of 10 mm Hg or greater from discharge or at 30 days to last echocardiography with a final mean gradient of 20 mm Hg or greater or (2) new-onset moderate or severe intraprosthetic aortic regurgitation or an increase of 1 grade or more. RESULTS: Of 4762 included patients, 2605 (54.7%) were male, and the mean (SD) age was 82.1 (7.4) years. A total of 2099 RCT patients, including 1128 who received TAVI and 971 who received surgery, and 2663 non-RCT patients who received TAVI were included. The cumulative incidence of SVD treating death as a competing risk was lower in patients undergoing TAVI than surgery (TAVI, 2.20%; surgery, 4.38%; hazard ratio [HR], 0.46; 95% CI, 0.27-0.78; P = .004). This lower risk was most pronounced in patients with smaller annuli (23 mm diameter or smaller; TAVI, 1.32%; surgery, 5.84%; HR, 0.21; 95% CI, 0.06-0.73; P = .02). SVD was associated with increased 5-year all-cause mortality (HR, 2.03; 95% CI, 1.46-2.82; P < .001), cardiovascular mortality (HR, 1.86; 95% CI, 1.20-2.90; P = .006), and valve disease or worsening heart failure hospitalizations (HR, 2.17; 95% CI, 1.23-3.84; P = .008). Predictors of SVD were developed from multivariate analysis. CONCLUSIONS AND RELEVANCE: This study found a lower rate of SVD in patients undergoing self-expanding TAVI vs surgery at 5 years. Doppler echocardiography was a valuable tool to detect SVD, which was associated with worse clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT01240902, NCT01586910, and NCT01531374.
引用
- O'Hair D, Yakubov SJ, Grubb KJ, et al. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. JAMA Cardiol. 2023. PMID: 36515976. doi:10.1001/jamacardio.2022.4627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。